# TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection

> **NCT00164450** · NA · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 230 (estimated)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Rifapentine + isoniazid once weekly for 3 months

## Key facts

- **NCT ID:** NCT00164450
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2008-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164450, "TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00164450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*